key: cord-0768334-mruxynrx
authors: Haghighi Aski, Behzad; Manafi Anari, Ali; Abolhasan Choobdar, Farhad; Zareh Mahmoudabadi, Ramin; Sakhaie, Maryam
title: Cardiac abnormalities due to multisystem inflammatory syndrome temporally associated with Covid-19 among children: A systematic review and meta-analysis
date: 2021-03-22
journal: Int J Cardiol Heart Vasc
DOI: 10.1016/j.ijcha.2021.100764
sha: 54d3020cf699a398a93ad4eee59a54b2df19fe77
doc_id: 768334
cord_uid: mruxynrx

BACKGROUND: Cardiac defects due to multisystem inflammatory syndrome in children (MIS-C) have been abundantly reported leading high morbidity among children affected by Covid-19. We aimed to systematically assess the incidence of such cardiac abnormalities due to MIS-C in children suffering Covid-19. METHODS: The manuscript databases including Medline, Web of knowledge, Google scholar, Scopus, and Cochrane were deeply searched by the two blinded investigators for all eligible studies based on the relevant keywords. The risk of bias for each study was assessed according to QUADAS-2 tool. Statistical analysis was performed using the Comprehensive Meta Analysis (CMA) software. RESULTS: In final, 21 articles (including 916 children) were eligible for the final analysis that all yielded good quality and none of the citation was determined to have high risk of bias. Considering studies focusing different cardiac abnormalities related to MIS-C yielded a pooled prevalence of 38.0% for significant left ventricular dysfunction, 20.0% for coronary aneurism or dilatation, 28.1% for ECG abnormalities or cardiac arrhythmias, 33.3% for raised serum troponin level and 43.6% for raised proBNP/BNP level. CONCLUSION: Although cardiac abnormalities among children suffering Covid-19 are uncommon, in the context of the MIS-C can be common and therefore potentially serious and life threatening.

Until the current writing, more than 68 million cases of Covid-19 have been reported worldwide, leading to more than 1.5 million deaths (1) . Apart from the pulmonary effects and disabilities associated with the progression of the infection, cardiovascular disorders have been reported in patients suffering this disorder (2) . Coronary atherosclerosis leading to myocardial infarction, myocarditis, valvular defects, peripheral vascular complications due to increased coagulpathies, and even acute heart failure due to severe left ventricular dysfunction have all been reported complications of the disease (3) (4) (5) . The probable mechanisms related to cardiac injuries include both direct invasion of virus leading cardiomyocyte death or indirect myocardial injury due to activation of inflammatory or coagulative cascades, hypoxemia, or metabolic disturbances (6) .

Less information is available about children with the disease and its potential complications in childhood, and according to some claims, children are at a much lower risk of contracting and dying from the disease (7) . Also, cardiac abnormalities among children suffering Covid-19 is infrequent finding, however it can be life-threatening and also with permanent heart defects (8) .

Although the incidence of cardiac abnormalities related to Covid-19 are uncommon among children (with an overall incidence of 0.6%) (9) , the occurrence of such abnormalities in the background of critical situation such as multisystem inflammatory syndrome in children (MIS-C) has been frequently reported (10) . According to the definition released by the World Health Organization (WHO), MIS-C is characterized in Children and adolescents (aged 0 to 19 years) by appearing fever (more than three days) with at least two of the following findings: 1) rash or bilateral non-purulent conjunctivitis or muco-cutaneous inflammation signs, 2) hypotension or shock, 3) any evidences of cardiac dysfunction along with raising Troponin and NT-proBNP levels, 4) any evidence of coagulopathy, 5) acute gastrointestinal problems, 6) increasing inflammatory markers such as ESR and CRP, all in the background of Covid-19 disease (11) . As reported in the last months, cardiac defects due to MIS-C have been abundantly reported leading high morbidity among children affected by Covid-19 (12) . However, so far no consensus has been reached on such cardiac complications. We aimed to systematically assess the incidence of such cardiac abnormalities due to MIS-C in children suffering Covid-19 that in this way, it is possible to identify the various dimensions of such cardiac defects and improve the survival of the affected children.

The present systematic review and meta-analysis followed the guideline for the Preferred Reporting Items for Systematic review and Meta-Analysis (PRISMA). Firstly, the main study questions was suggested based on the authors purposes as "What is the prevalence of each of the cardiac abnormalities caused by MIS-C in the relation to Covid-19 among children?" In the next step, the manuscript databases including Medline, Web of knowledge, Google scholar, Scopus, and Cochrane were deeply searched by the two blinded investigators for all eligible studies based on the considered keywords including "children", "Covid-19", "multisystem inflammatory syndrome", "heart", and "cardiovascular". The inclusion criteria were considered to retrieve the studies: 1) the studies finally assessed different aspects of cardiovascular defects related to MIS-C among children suffering Covid-19, 2) The studies were restricted to English language, 3) the studies with unclear or irreproducible results were all excluded, 4) lack of access to the manuscripts full texts was also considered as the inclusion criteria unless the abstracts had enough data for our analysis, 5) case reports and review papers were all excluded. As shown in the flow diagram of the study selection ( Figure 1 ), 33 articles were initially collected by database searching. After removing 2 articles due to evidences of duplication, 31 records were primarily under-screened.

Based on the titles and abstracts, 8 records were excluded and the remaining 23 citations were assessed for further eligibility. Of those, 2 were also excluded due to incompleteness of the data and contents. In final, 21 articles were eligible for the final analysis (13-33) ( Table 1) .

Data abstraction was independently performed by two un-blinded reviewers on structure collection forms without divergences in data collection. We resolved disagreements by consensus or by involving a third person. The study quality was evaluated based on the following criteria: 1) the systematic review and meta-analysis based on the questions primarily described and formulated;

2) inclusion and exclusion criteria predefined in the studies as eligibility criteria; 3) searching the literature performed on a systematic and comprehensive approach; 4) to minimize the bias, the full texts of the article were dually reviewed; 5) the quality of included studies were rated independently by the reviewers for appraising internal validity; 6) studies' characteristics and findings were comprehensively listed; 7) the publication and risk of bias were listed; and 8) heterogeneity was also assessed. The risk of bias for each study was assessed using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions and also according to QUADAS-2 tool. Any disagreement was resolved by discussion in the whole study team.

Dichotomous variables are reported as proportions and percentages. The pooled prevalence for each cardiac defect was assessed and presented by the pooled prevalence and 95% confidence interval (CI) as summary statistics. Cochran's Q test was used to determine the statistical heterogeneity. This test was complemented with the I2 statistic, which quantifies the proportion of total variation across studies that is due to heterogeneity rather than chance. Publication bias was assessed by the rank correlation test and also confirmed by the funnel plot analysis. Reported values were two-tailed, and hypothesis testing results were considered statistically significant at p = 0.05. Statistical analysis was performed using the Comprehensive Meta Analysis (CMA) software version 3.0 (Biostat, Englewood, NJ 07631 USA).

To assess the prevalence of cardiac abnormalities related to MIS-C based on applied keywords, in total 21 studies finally assessed that published from different countries between February and October 2020 (Table 1 ). According to our risk of bias assessment, all 21 studies yielded good quality and none of the citation was determined to have high risk of bias and therefore the pooled results should be persuasive ( Figure 2 ). In total, 916 children were assessed indicating higher rate of boys than girls. The median age of the patients on admission was 9 years ranged 3 to 14 year.

Contrary to the impression, the molecular assessment of virus using the RT-PCR (Figure 3) (Figure 4a to 4e). The statistical heterogeneity was significant for all events assessment with I 2 values ranged 75.456 to 97.249 (P < 0.001). The authors believed that the pointed heterogeneities were sourced from the differences in the interpretation of the ECG or echocardiography by specialists and also the lack of calibration of the instruments used. There was also a significant publication bias as evidenced by either funnel plot asymmetry or Egger test for all assessments due to the publishers' desire to publish articles with significant and positive results. The main echocardiography findings in the studies evaluated were hypokinesia of the left ventricular wall and interventricular septum, left ventricular dilatation, mild to moderate pericardial effusion, mild mitral regurgitation, cardiogenic shock, myocarditis, or coronary artery dilatation/aneurism/ectasia. Regarding ECG abnormalities, the prominent findings included ST-segment elevation or depression, Junctional cardiac rhythm, atrial fibrillation, sinus bradycardia, QT interval prolongation, ventricular arrhythmias, and atrioventricular block.

According to the findings of the present systematic review and meta-analysis, various dimensional and functional changes are expected following MIS-C due to Covid-19 in children. In this regard, both left ventricular myocardial tissue as well as coronary arteries can be affected significantly by such critical situation so that overall more than one-third of the patients may show a degree of such abnormal cardiac conditions. As analyzed finally, about 38.0% of the pointed children suffered from significant (mild to moderate) left ventricular dysfunction which accompanied with diffuse left ventricular hypokinesia along with dilatation, 20.0% from coronary arteries involvement as aneurism, dilatation or ectasia, and 28.1% from different types of ECG abnormalities as atrial or ventricular arrhythmias. Interestingly, such cardiac changes could be accompanied with the raise of both cardiac enzyme (troponin) and also cardiac function-related proteins (NT-proBNP) in 33.3% and 43.6% respectively. The evidences have been shown that mild cardiac changes in those children suffering Covid-19 (7, 8) 

COVID-19) Dashboard. The World Heart Organization, Data last updated: 2020/12/9

COVID-19 and cardiovascular diseases

Cardiovascular disease and COVID-19

COVID-19 and Cardiovascular Disease

COVID-19 and the Heart

Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review

Epidemiology of COVID-19 among children in China

Multisystem inflammatory syndrome in children: A systematic review

Emergency preparedness and response: health alert network

Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children

Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic

Cardiac MRI of children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19: case series Eléonore

Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York city

Multisystem inflammatory syndrome in children during the COVID-19 pandemic: a case series

Multisystem inflammatory syndrome in children in New York state

Multisystem inflammatory syndrome in U.S. children and adolescents

COVID-19-Related Multisystem Inflammatory Syndrome in Children Affects Left Ventricular Function and Global Strain Compared with Kawasaki Disease

Acute myocarditis and multisystem inflammatory emerging disease following SARSCoV-2 infection in critically ill children

Multisystem inflammatory syndrome in children (MIS C) associated with SARSCoV-2 infection: a multi-institutional study from New York

Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States

Sourabh Verma 2, Rakesh K Singh 1. Cardiac Findings in Pediatric Patients With Multisystem Inflammatory Syndrome in Children Associated With COVID-19

Paediatric multisystem inflammatory syndrome temporally associated with SARSCoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Paediatric inflammatory multisystem syndrome: temporally associated with SARSCoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital

Hyperinflammatory shock in children during COVID-19 pandemic

Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19

Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic

Giridhar Soda 11. Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe. Circulation

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARSCoV-2 epidemic: an observational cohort study

Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department

Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2

Acute myocardial injury: a novel clinical pattern in children with COVID-19

Clinical Guidance for Pediatric Patients with

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARSCoV-2 and